Bio-Key International Inc (BKYI) Stock Up 24.44%: Is It a Good Investment?

A share price of Bio-Key International Inc [BKYI] is currently trading at $1.12, up 24.44%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BKYI shares have gain 27.27% over the last week, with a monthly amount drifted -15.15%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Bio-Key International Inc [NASDAQ: BKYI] stock has seen the most recent analyst activity on March 26, 2021, when Maxim Group upgraded its rating to a Buy but kept the price target unchanged to $6 for it.

Bio-Key International Inc experienced fluctuations in its stock price throughout the past year between $0.52 and $4.43. Bio-Key International Inc [NASDAQ: BKYI] shares were valued at $1.12 at the most recent close of the market.

Analyzing the BKYI fundamentals

Trailing Twelve Months sales for Bio-Key International Inc [NASDAQ:BKYI] were 6.39M which represents 18.03% growth. Gross Profit Margin for this corporation currently stands at 0.15% with Operating Profit Margin at -1.45%, Pretax Profit Margin comes in at -1.47%, and Net Profit Margin reading is -1.42%. To continue investigating profitability, this company’s Return on Assets is posted at -1.42, Equity is -53.78 and Total Capital is -17.5. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of17.97.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.9600 points at the first support level, and at 0.8000 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.2300, and for the 2nd resistance point, it is at 1.3400.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Bio-Key International Inc [NASDAQ:BKYI] is 0.78. As well, the Quick Ratio is 0.71, while the Cash Ratio is 0.31. Considering the valuation of this stock, the price to sales ratio is 0.54, the price to book ratio is 26.17.

Related Posts